Suppr超能文献

事件性利尿剂使用与随后骨折风险:一项针对美国退伍军人的全国性大型观察性研究。

Incident Diuretic Use and Subsequent Risk of Bone Fractures: A Large Nationwide Observational Study of US Veterans.

机构信息

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

Center for Health System Improvement, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

出版信息

Mayo Clin Proc. 2024 Jun;99(6):913-926. doi: 10.1016/j.mayocp.2023.09.018. Epub 2024 Apr 4.

Abstract

OBJECTIVE

To investigate the association of incident use of diuretics with subsequent risk of incident bone fractures.

PATIENTS AND METHODS

In a nationwide cohort of 863,339 US veterans receiving care from the VA health care system between October 1, 2004, and September 30, 2006, with follow-up through June 30, 2018, we examined the association of incident diuretic use (overall, and separately by thiazide, loop, and potassium-sparing diuretics) with subsequent risk of incident bone fractures using multivariable Cox regression models while minimizing confounding by indication using a target trial emulation approach.

RESULTS

Patients were 63.3±12.9 years old; 93.5% (n=807,180) were male; and 27.1% (n=233,996) were diabetic. Their baseline estimated glomerular filtration rate was 84.4±16.5 mL/min per 1.73 m. Among 863,339 patients, 424,386 (49.2%) newly initiated diuretics, of which 77.4% (n=328,524), 22.5% (n=95,457), and 0.1% (n=405) were thiazide, loop, and potassium-sparing diuretic users, respectively. After multivariable adjustments, incident diuretic use (vs non-use) was significantly associated with higher risk of incident fracture (adjusted HR [aHR], 1.14; 95% CI, 1.11 to 1.16). The association was most pronounced for loop diuretics (aHR, 1.39; 95% CI, 1.35 to 1.44) but less evident for thiazide diuretics (aHR, 1.08; 95% CI, 1.06 to 1.10) and was not significant for potassium-sparing diuretics (aHR, 0.97; 95% CI, 0.62 to 1.52). The diuretic-fracture association was more evident in younger (vs older) patients, those with (vs without) corticosteroid use, and those with lower (vs higher) serum sodium levels.

CONCLUSION

Incident use of diuretics, particularly loop diuretics, was independently associated with higher risk of incident bone fractures. Our findings suggest distinct pathophysiologic contributions of diuretics to bone metabolism and the need for careful attention to skeletal outcomes when initiating diuretics.

摘要

目的

研究利尿剂的新用与随后发生骨骨折风险之间的关联。

方法

在一项针对 863339 名在美国退伍军人事务部医疗保健系统接受治疗的美国退伍军人的全国性队列研究中,我们于 2004 年 10 月 1 日至 2006 年 9 月 30 日进行了研究,随访至 2018 年 6 月 30 日,我们使用多变量 Cox 回归模型检查了新使用利尿剂(整体,以及分别使用噻嗪类、环利尿剂和保钾利尿剂)与随后发生骨骨折风险之间的关联,同时使用目标试验模拟方法最小化指示性混淆。

结果

患者年龄为 63.3±12.9 岁;93.5%(n=807180)为男性;27.1%(n=233996)患有糖尿病。他们的基线估算肾小球滤过率为 84.4±16.5mL/min/1.73m。在 863339 名患者中,424386 名(49.2%)新开始使用利尿剂,其中 77.4%(n=328524)、22.5%(n=95457)和 0.1%(n=405)分别为噻嗪类、环利尿剂和保钾利尿剂使用者。经过多变量调整后,新使用利尿剂(与未使用者相比)与更高的骨折风险显著相关(调整后的 HR[aHR],1.14;95%CI,1.11 至 1.16)。这种关联在环利尿剂中最为明显(aHR,1.39;95%CI,1.35 至 1.44),但在噻嗪类利尿剂中则不太明显(aHR,1.08;95%CI,1.06 至 1.10),而在保钾利尿剂中则不显著(aHR,0.97;95%CI,0.62 至 1.52)。在较年轻(与较年长)患者、使用皮质类固醇(与未使用皮质类固醇)的患者和血清钠水平较低(与较高)的患者中,利尿剂与骨折之间的关联更为明显。

结论

利尿剂的新用,特别是环利尿剂的新用,与骨骨折风险的增加独立相关。我们的研究结果表明,利尿剂对骨骼代谢有不同的病理生理作用,在开始使用利尿剂时需要仔细注意骨骼结局。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验